Esuprone
![]() | |
Names | |
---|---|
IUPAC name
3,4-Dimethyl-2-oxo-2H-chromen-7-yl ethanesulfonate | |
Identifiers | |
91406-11-0 ![]() | |
ChEMBL | ChEMBL18504 ![]() |
ChemSpider | 59239 ![]() |
Jmol interactive 3D | Image |
PubChem | 65827 |
UNII | K7EB9E48ZE ![]() |
| |
| |
Properties[1] | |
C13H14O5S | |
Molar mass | 282.31 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
![]() ![]() ![]() | |
Infobox references | |
Esuprone is an experimental drug candidate being investigated as an antidepressant.[2] It acts as an monoamine oxidase A (MAO-A) inhibitor.[3]
References
- ↑ Ganellin, C. R (1996). Dictionary of pharmacological agents. CRC Press. p. 1056. ISBN 978-0-412-46630-4.
- ↑ Vértes, Attila (2003). Handbook of nuclear chemistry. Springer. p. 155. ISBN 978-1-4020-1316-4.
- ↑ Bergström, M; Westerberg, G; Németh, G; Traut, M; Gross, G; Greger, G; Müller-Peltzer, H; Safer, A; et al. (1997). "MAO-A inhibition in brain after dosing with esuprone, moclobemide and placebo in healthy volunteers: In vivo studies with positron emission tomography". European journal of clinical pharmacology 52 (2): 121–8. doi:10.1007/s002280050260. PMID 9174681.
This article is issued from Wikipedia - version of the Monday, November 16, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.